Boston Scientific Corporation (BSX) financial statements (2020 and earlier)

Company profile

Business Address 300 BOSTON SCIENTIFIC WAY
MARLBOROUGH, MA 01752-1234
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments277146188196319587217
Cash and cash equivalents277146188196319587217
Restricted cash and investments357655     
Receivables1,7961,6081,5481,4721,2751,1831,307
Inventory, net of allowances, customer advances and progress billings1,5661,1661,0789551,016946897
Inventory1,5661,1661,0789551,016946897
Prepaid expense and other current assets302
Other current assets   240   
Other undisclosed current assets8514281,008376861890288
Total current assets:4,8474,0033,8223,2393,4713,6063,011
Noncurrent Assets
Property, plant and equipment1,9421,7821,6971,6301,4901,5071,546
Long-term investments and receivables     3738
Long-term investments     3738
Intangible assets, net (including goodwill)18,08914,28312,83512,56112,66711,50411,643
Goodwill10,0157,9116,9986,6786,4735,8985,693
Intangible assets, net (excluding goodwill)8,0746,3725,8375,8836,1945,6065,950
Other noncurrent assets1,879932688666505425 
Prepaid expense and other noncurrent assets371
Other undisclosed noncurrent assets(1)(1)   (37)(38)
Total noncurrent assets:21,90916,99615,22014,85714,66213,43613,560
TOTAL ASSETS:26,75620,99919,04218,09618,13317,04216,571
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,4442,5952,9862,7592,1792,7242,082
Accounts payable512349530447209262246
Accrued liabilities1,9322,2462,4562,3121,9701,9501,348
Employee-related liabilities     512488
Debt1,2972,2531,8016434033
Estimated litigation liability     69484
Business combination, contingent consideration, liability     158
Deferred tax liabilities    22
Other liabilities513412867764248231227
Other undisclosed current liabilities     (1,366)(574)
Total current liabilities:4,2545,2605,6543,5872,4302,8461,824
Noncurrent Liabilities
Long-term debt and lease obligation, including:9,5904,8033,8155,4205,6743,8594,237
Other undisclosed long-term debt and lease obligation9,5904,8033,8155,4205,6743,8594,237
Liabilities, other than long-term debt3,2132,2102,5612,3563,7096,5465,777
Accounts payable and accrued liabilities     1,667 
Accrued income taxes1,283
Deferred tax liabilities, net807328191187351,2141,402
Estimated litigation liability     883523
Other liabilities2,4061,8822,3702,3382,9742,6662,569
Business combination, contingent consideration, liability     116
Other undisclosed noncurrent liabilities     (2,666)(1,806)
Total noncurrent liabilities:12,8037,0136,3767,7769,3837,7398,208
Total liabilities:17,05712,27312,03011,36311,81310,58510,032
Stockholders' equity
Stockholders' equity attributable to parent9,6988,7257,0116,7336,3206,4576,539
Common stock16161616161616
Treasury stock, value(1,717)(1,717)(1,717)(1,717)(1,717)(1,717)(1,592)
Additional paid in capital17,51017,34617,16117,01416,86016,70316,579
Accumulated other comprehensive income (loss)13833(59)188144106
Accumulated deficit(6,249)(6,953)(8,390)(8,581)(8,927)(8,689)(8,570)
Other undisclosed stockholders' equity111    
Total stockholders' equity:9,6998,7267,0126,7336,3206,4576,539
TOTAL LIABILITIES AND EQUITY:26,75620,99919,04218,09618,13317,04216,571

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues10,3929,8239,0489,0768,0687,4627,143
Revenue, net9,0488,3867,4777,3807,143
Cost of revenue
(Cost of Goods and Services Sold)
(2,994)(2,813)(2,593)(2,424)(2,173)(2,210)(2,174)
Other undisclosed gross profit 1 (690)(591)(82) 
Gross profit:7,3987,0116,4555,9625,3045,1704,969
Operating expenses(5,770)(5,504)(5,170)(5,515)(5,631)(5,471)(4,849)
Other undisclosed operating loss(1)(1)     
Operating income (loss):1,6271,5061,285447(327)(301)120
Nonoperating income (expense)(639)(85)(353)(270)(69)298
Investment income, nonoperating 155(92)(21)(9)3938
Foreign currency transaction loss, before tax   (13)(21)(18)(11)
Other nonoperating income (expense)(322)156(124)(37)(39)8(19)
Interest and debt expense(357)(241)(229)(233)(284)(216)(324)
Income (loss) from continuing operations before equity method investments, income taxes:6311,180703(56)(680)(488)(196)
Other undisclosed income (loss) from continuing operations before income taxes35824223023330(21)(27)
Income (loss) from continuing operations before income taxes:9891,422933177(650)(509)(223)
Income tax expense (benefit)101249(828)170411390102
Income (loss) before gain (loss) on sale of properties:1,0901,671105347(239)(119)(121)
Other undisclosed net loss  (1)    
Net income (loss) available to common stockholders, diluted:1,0901,671104347(239)(119)(121)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):1,0901,671104347(239)(119)(121)
Other comprehensive income (loss)11491(59)(87)(56)38139
Other undisclosed comprehensive loss(1)(1)     
Comprehensive income (loss), net of tax, attributable to parent:1,2031,76145260(295)(81)18

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: